DHA, ARA Benefit Preterm Infants, Research Shows; Formulas On Horizon
This article was originally published in The Tan Sheet
Executive Summary
Infant formula fortified with docosahexaenoic acid (DHA) and arachidonic acid (ARA) provide significant growth benefits over non-fortified formula in preterm infants, study results indicate
You may also be interested in...
Enfamil Premature LIPIL
New preterm infant formula contains same levels of docosahexaenoic acid, arachidonic acid as regular LIPIL, Mead Johnson says. Launching this month in 3 oz., ready-to-use bottles, formula will be distributed to hospitals, healthcare professionals and direct to consumers through a toll-free number. Mead announced July 9 FDA had no concerns regarding its premarket notification for the product. BMS division says formula's growth, development benefits for preterm infants are demonstrated by studies presented at Pediatric Academic Societies' annual meeting in May (1"The Tan Sheet" April 29, 2002, p. 22). Similac Advance marketer Ross Products says it also expects to launch fortified preterm formula upon agency clearance of its premarket notification. Abbott Labs' division's second quarter sales were flat at $515 mil., company announced July 11...
Enfamil Premature LIPIL
New preterm infant formula contains same levels of docosahexaenoic acid, arachidonic acid as regular LIPIL, Mead Johnson says. Launching this month in 3 oz., ready-to-use bottles, formula will be distributed to hospitals, healthcare professionals and direct to consumers through a toll-free number. Mead announced July 9 FDA had no concerns regarding its premarket notification for the product. BMS division says formula's growth, development benefits for preterm infants are demonstrated by studies presented at Pediatric Academic Societies' annual meeting in May (1"The Tan Sheet" April 29, 2002, p. 22). Similac Advance marketer Ross Products says it also expects to launch fortified preterm formula upon agency clearance of its premarket notification. Abbott Labs' division's second quarter sales were flat at $515 mil., company announced July 11...
Enfamil Premature LIPIL
New preterm infant formula contains same levels of docosahexaenoic acid, arachidonic acid as regular LIPIL, Mead Johnson says. Launching this month in 3 oz., ready-to-use bottles, formula will be distributed to hospitals, healthcare professionals and direct to consumers through a toll-free number. Mead announced July 9 FDA had no concerns regarding its premarket notification for the product. BMS division says formula's growth, development benefits for preterm infants are demonstrated by studies presented at Pediatric Academic Societies' annual meeting in May (1"The Tan Sheet" April 29, 2002, p. 22). Similac Advance marketer Ross Products says it also expects to launch fortified preterm formula upon agency clearance of its premarket notification. Abbott Labs' division's second quarter sales were flat at $515 mil., company announced July 11...